ABU DHABI 10 December 2020: The Ministry of Health and Prevention (MoHAP) conducted 149,798 Covid-19 tests, and announced 1,313 new cases, bringing the total in the UAE to 180,150.
It also announced 2 deaths due to complications, bringing the total number of deaths in the country to 598.
MoHAP also noted that an additional 789 individuals had fully recovered, bringing the total number of recoveries to 161,084.
Inactivated #4Humanity trials vaccine registered
MoHAP has announced the official registration of Beijing Institute of Biological Product’s inactivated Covid-19 vaccine
The registration is a decision in response to the application from Sinopharm CNBG. The announcement is a significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.
MoHAP, in collaboration with Department of Health Abu Dhabi has reviewed Sinopharm CNBG’s interim analysis of the phase III trials, which shows Beijing Institute of Biological Product’s inactivated vaccine to have 86 percent efficacy against Covid-19 infection. The analysis also shows the vaccine to have 99 percent seroconversion rate of neutralising antibody and 100 percent effectiveness in preventing moderate and severe cases of the disease. Furthermore, the analysis shows no serious safety concerns.
This vaccine was granted Emergency Use Authorisation (EUA), since September to protect frontline workers most at risk of Covid-19. The UAE is conducting Post Authorisation Safety Study, and Post Authorisation Efficacy Study, of its EUA programme. These ongoing studies show similar safety and efficacy profiles as the interim analysis.
The #4Humanity phase III trials have included 31,000 volunteers across 125 nationalities in the UAE alone. The EUA vaccination programme has effectively safeguarded the UAE frontline workers. MoHAP’s official registration of Beijing Institute of Biological Product’s inactivated Covid-19 vaccine leads the way to comprehensively protecting the population and responsibly opening the economy.
